Gene: ZNF672
Official Full Name: zinc finger protein 672provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12078 | ZNF672 Knockout cell line (HeLa) | Human | ZNF672 | 1:3~1:6 | Negative | Online Inquiry |
KO12079 | ZNF672 Knockout cell line (HCT 116) | Human | ZNF672 | 1:2~1:4 | Negative | Online Inquiry |
KO12080 | ZNF672 Knockout cell line (HEK293) | Human | ZNF672 | 1:3~1:6 | Negative | Online Inquiry |
KO12081 | ZNF672 Knockout cell line (A549) | Human | ZNF672 | 1:3~1:4 | Negative | Online Inquiry |
ZNF672 Gene Knockout Cell Lines are genetically engineered cell models designed to facilitate the study of the ZNF672 gene's functional role in various biological processes. These knockout cell lines have been generated using advanced CRISPR-Cas9 technology, enabling the precise deletion of the ZNF672 gene, leading to the observation of the resultant phenotypic changes. This robust mechanism allows researchers to investigate gene function by comparing the knockout cells to their wild-type counterparts, thereby enhancing our understanding of gene interactions, signaling pathways, and cellular behavior.
The scientific importance of ZNF672 gene knockout cell lines lies in their potential applications across multiple research domains, including cancer biology, neurobiology, and developmental studies. Understanding the role of ZNF672 could reveal crucial insights into its involvement in regulatory networks, contributing to disease pathogenesis and potential therapeutic targets. Clinically, these cell lines facilitate the development of novel treatment strategies by allowing for the identification of gene function in disease contexts, ultimately enabling the design of more targeted interventions.
Compared to traditional methods of gene silencing, such as RNA interference, ZNF672 knockout cell lines provide a more stable and lasting modification, enabling long-term studies without the variability associated with transient knockdown approaches. Additionally, the precise editing afforded by CRISPR technology reduces off-target effects, yielding more reliable data.
Researchers and clinicians can greatly benefit from these knockout cell lines, as they offer a crucial tool for elucidating gene function and mechanism, accelerating the pace of discovery in both basic and translational science. The availability of well-characterized ZNF672 knockout cell lines represents a significant advancement in the toolkit of molecular biologists and geneticists.
Our company is committed to advancing genetic research by offering high-quality, rigorously validated biological products, ensuring that scientists have access to the tools necessary to push the boundaries of knowledge and innovation in their respective fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.